Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow Reinvestment Rate

Latest as of September 2025: 0.06x

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow reinvestment rate. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥6.99 Million (capex CN¥6.99 Million ) from operating cash flow of CN¥109.83 Million. Explore how well can Shanghai Shenqi Pharmaceutical Investmen service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.06x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥6.99 Million
Capex + Investments

Operating Cash Flow

CN¥109.83 Million
CNY

Capital Expenditures

CN¥6.99 Million
CNY

Cash Flow Reinvestment Rate of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)

Cash flow reinvestment rate of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. Historical reinvestment intensity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 22 annual periods. Explore 600613 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow Reinvestment Rate by Year (1998–2025)

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For the full cash flow conversion analysis, see Shanghai Shenqi Pharmaceutical Investmen cash conversion from operations.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 1.61x CN¥200.34 Million CN¥124.47 Million CN¥33.22 Million ▲ +792.5%
2024 0.18x CN¥37.47 Million CN¥207.79 Million CN¥36.39 Million ▼ -11.7%
2023 0.20x CN¥44.05 Million CN¥215.59 Million CN¥24.51 Million ▲ +27.6%
2022 0.16x CN¥51.12 Million CN¥319.23 Million CN¥26.64 Million ▼ -66.2%
2021 0.47x CN¥87.36 Million CN¥184.26 Million CN¥85.96 Million ▼ -51.7%
2020 0.98x CN¥97.34 Million CN¥99.10 Million CN¥96.31 Million ▲ +56.8%
2019 0.63x CN¥80.35 Million CN¥128.28 Million CN¥76.96 Million ▼ -16.3%
2018 0.75x CN¥111.15 Million CN¥148.53 Million CN¥110.25 Million ▼ -56.2%
2017 1.71x CN¥114.33 Million CN¥66.99 Million CN¥108.84 Million ▼ -98.0%
2016 83.30x CN¥47.52 Million CN¥570.41K CN¥42.87 Million ▲ +3635.5%
2015 2.23x CN¥67.16 Million CN¥30.12 Million CN¥66.18 Million ▲ +199.9%
2013 0.74x CN¥55.58 Million CN¥74.75 Million CN¥55.58 Million ▲ +4176.6%
2010 0.02x CN¥574.38K CN¥33.04 Million CN¥574.38K ▼ -85.3%
2009 0.12x CN¥907.90K CN¥7.69 Million CN¥907.90K ▲ +741.2%
2008 0.01x CN¥354.57K CN¥25.26 Million CN¥354.57K ▼ -75.2%
2007 0.06x CN¥906.84K CN¥16.01 Million CN¥906.84K ▼ -47.0%
2005 0.11x CN¥3.50 Million CN¥32.72 Million CN¥3.50 Million ▼ -91.6%
2004 1.27x CN¥6.29 Million CN¥4.96 Million CN¥6.29 Million ▲ +808.9%
2003 0.14x CN¥629.83K CN¥4.52 Million CN¥629.83K ▼ -31.0%
2002 0.20x CN¥3.24 Million CN¥16.02 Million CN¥3.24 Million ▼ -53.8%
2000 0.44x CN¥11.76 Million CN¥26.85 Million CN¥11.76 Million ▲ +2282.2%
1998 0.02x CN¥1.34 Million CN¥72.67 Million CN¥1.34 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow